Sreeleathers Ltd
SREELSreeleathers Ltd is coiled. The quarters are improving, yet the P/E sits at the 16th percentile of its own 10-year range — the business is moving before the market.
Biggest watch item: the price is not yet in a confirmed uptrend — timing risk, not thesis risk.
The price is building a base (3 weeks in) while the P/E sits at the 16th percentile of its own 10-year range. Underneath, the last four quarters read improving — profit +82.8% year on year, and 111% of the last 3 years' profit arrived as cash. What settles it: the next one or two quarters of delivery.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Sreeleathers Ltd trades at ₹217, building a base and 3 weeks into that stage. That is +3.1% against its own 200-day average. It sits at 74% of a 52-week range of ₹184 to ₹228. On relative strength it has no relative-strength read yet.
Today the stock is building a base — week 3 of stage 1, confirmed. At ₹217 it trades +3.1% versus its 200-day average and sits at 74% of its 52-week range (₹184–₹228).
Against the market, two honest reads. Cumulative: over the last 2 months the stock moved +18% while the NIFTY 500 moved +5% — ahead of the index over the full window. Recent form: no trailing-13-week read yet — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Sreeleathers Ltd trades at 17.4× P/E, near the bottom of its own range — cheaper only 16% of the time. Its long-run median P/E is 24.4×, measured across 10.1 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 17.4× is near the bottom of its own range — cheaper only 16% of the time, against a long-run median of 24.4× measured over 10.1 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Put together: the multiple is low against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: Improving Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Sreeleathers Ltd reads as improving on its fundamental arc. Improving — profit growth bottomed 8 quarters ago at −29.0% and has held its recovery at +82.8% (single-quarter readings), ROCE holding at 8.0%. The read is built from 9 quarters across 3 curves, on partial evidence.
Why it matters: a sustained climb off the trough is the setup this page is built to catch — the question moves to what you pay for it.
One or more growth curves carry a base-effect spike — a large year-on-year move off a near-zero or loss-making comparable quarter. Those spikes are capped before the classifier reads the trajectory, and shown pinned on the chart, so a single distorted quarter does not drive the stage call.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
A partial read: at least one curve is short, or the returns curve is not the computed quarterly series — hold the stage word a little more loosely.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +14.3% | +7.8% | +24.5% | +12.0% |
| Profit | +26.1% | +3.7% | +21.4% | +10.2% |
| EPS | +27.3% | +3.9% | +20.9% | +10.7% |
4-Factor Sector Score
55.5/100 — rank 2 of 7 in Footwear · 68% evidence confidence
Sreeleathers Ltd scores 55.5 out of 100 against the 7 companies it is compared with in Footwear, ranking 2. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 22.9 + 10.1 + 12 + 10.5 = 55.5. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Sreeleathers Ltd reported ₹62.7 Cr of revenue in the Mar 26 quarter, +17.9% year on year. That is the 5th straight quarter of year-on-year growth. Over 10 years it has compounded at 12.0% a year. The last full year, FY26, came in at ₹248 Cr. The last four reported quarters add to ₹248 Cr.
FY26 revenue came in at ₹248 Cr (+14.3% on the year), capping 10 years at 12.0% compound. The latest quarter (Mar 26) printed ₹62.7 Cr, +17.9% year on year — the 5th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +12.5% growth against the decade's 12.0% — the current year is running in line with its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +13.0% over the last 4 quarters against +6.8%/yr over the last 8 — accelerating; TTM profit +27.3% vs +3.5%/yr — accelerating.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Sreeleathers Ltd's operating margin is 15.9% in the Mar 26 quarter, +3.3 percentage points against the same quarter a year ago. Across 12 fiscal years the operating margin has ranged 14.0% to 23.0%. The current quarter sits inside that band.
The latest quarter's operating margin is 15.9%, +3.3 pp against the same quarter a year ago. Across 12 fiscal years the operating margin has ranged 14.0%–23.0%.
Why the margin moved: operating margin went +3.3 pp year on year while gross margin went +3.1 pp — the gain came mostly from the gross line: input costs and pricing.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Sreeleathers Ltd earned ₹9.7 Cr of net profit in the Mar 26 quarter, +82.8% year on year. It is the 3rd consecutive quarter of growth. Full-year FY26 profit was ₹29.0 Cr. The 10-year compound rate is 10.2%. That is 15.4% of the quarter's revenue. The same quarter a year earlier earned ₹5.3 Cr.
Mar 26 profit was ₹9.7 Cr, +82.8% year on year — the 3rd consecutive quarter of growth. On the full year, FY26 printed ₹29.0 Cr (+26.1%), and the 10-year compound rate is 10.2%.
Why profit moved: revenue contributed +17.9% and the margin +3.3 pp — the quarter was margin-led: most of the profit growth came from keeping more of each sale.
Pace comparison, last four quarters: profit +25.2% vs revenue +12.5%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra rupee of revenue drops more to the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 111% of Sreeleathers Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was ₹31.0 Cr of operating cash against ₹29.0 Cr of profit. After ₹0.0 Cr of capital spending, ₹31.0 Cr was left as free cash.
FY26: operating cash of ₹31.0 Cr against reported profit of ₹29.0 Cr, leaving free cash of ₹31.0 Cr after ₹0.0 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 111% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why conversion sits at 111%: the cash cycle tightened 41 days between FY21 and FY26 — cash that used to wait in the cycle now reaches the bank sooner.
Router verdict: no single sink dominates — the next section checks both the working-capital cycle and the capital spending.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Sreeleathers Ltd's cash conversion cycle runs −6 days in FY26, down from 35 days in FY21. Capital spending ran ₹3.0 Cr over the last 3 years. At FY26 sales of ₹248 Cr each day of that cycle holds about ₹0.7 Cr, so roughly ₹−4.0 Cr sits inside the business at any moment.
FY26: debtors at 1 days, inventory at 15 days — roughly 0.5 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of −6 days, tighter than FY21's 35.
The full loop: cash goes out to suppliers and production on day 0; stock waits 15 days to sell; customers pay about 1 days after that; and suppliers themselves are paid at 22 days — netting out to the −6-day cycle.
In money terms: at FY26 sales of ₹248 Cr, each day of the cycle holds about ₹0.7 Cr — so the −6-day loop keeps roughly ₹−4.0 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹3.0 Cr over the last 3 fiscal years against ₹3.0 Cr of depreciation — spending at or below maintenance level. Capital work-in-progress stands at ₹0.0 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: neither the cycle nor the build-out is hoarding the cash — the machine is reasonably clean.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.
Sreeleathers Ltd earns a ROCE of 8% in FY26. That is up from a trough of 5% in FY21. Return on invested capital clears the cost of that capital by −6.0 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is 11.7% net margin on 0.47× asset turns.
FY26 ROCE is 8%, recovered from a FY21 trough of 5% — the full ladder below shows the fall and the climb, undoctored.
🚨 Why the return is what it is — the wiring (FY26): 11.7% net margin × 0.47× asset turns × 1.06× balance-sheet leverage ≈ 5.8% on equity. Margin does its share; leverage is modest — this is an earned return, not a borrowed one.
The capstone test — ROIC − WACC: 6.0% − 12.0% = a −6.0 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.
Debt Debt-to-equity says how much of the business is funded by borrowings; interest cover says how many times operating profit pays the interest bill. Low and high, respectively, is the safe corner.
Sreeleathers Ltd carries ₹2.0 Cr of borrowings against ₹498 Cr of equity in FY26, a debt-to-equity of 0.00. Over 5 years borrowings went from ₹3.0 Cr to ₹2.0 Cr. Capital spending ran ₹3.0 Cr across the last 3 of those years.
FY26: borrowings of ₹2.0 Cr against equity of ₹498 Cr — a debt-to-equity of 0.00. Over 5 years borrowings went from ₹3.0 Cr to ₹2.0 Cr while capital spending ran ₹3.0 Cr in just the last 3 — the build-out is being paid for out of cash, not debt.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
No holder of Sreeleathers Ltd moved a full percentage point over the last two years — the register is quiet. Foreign institutions moved +0.0 points over the same window, to 6.9%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Promoters: +0.0 points over 8 quarters to 75.0%; Foreign institutions: +0.0 points over 8 quarters to 6.9%.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Sreeleathers Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Redtape LtdREDTAPE | 75.7/100Favorable setup96% evidence | FADING | 28.9/35 Revenue 19.5% · PAT 42.4% · OPM change 7 pp 88% evidence | 18.3/25 ROCE 24.5% · OPM 16% 100% evidence | 16.5/20 P/E 32.1× · PEG 1.19 100% evidence | 12.0/20 RS sector 11.2% · RS bench 5.2% · 1Y 10.8%8 of 12 weeks ahead 100% evidence |
| Exact sum: 28.9 + 18.3 + 16.5 + 12 = 75.7 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 2Sreeleathers Ltdthis pageSREEL | 55.5/100Mixed-positive evidence68% evidence | TURNING | 22.9/35 Revenue 12.9% · PAT 27.3% · OPM change 3.3 pp 83% evidence | 10.1/25 ROCE 8% · OPM 15.9% 95% evidence | 12.0/20 P/E 17.4× · PEG — 50% evidence | 10.5/20 RS sector — · RS bench -0.3% · 1Y —1 of 1 week ahead 25% evidence |
| Exact sum: 22.9 + 10.1 + 12 + 10.5 = 55.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3Metro Brands LtdMETROBRAND | 48.0/100Mixed-negative evidence94% evidence | ASLEEP | 16.4/35 Revenue 14.2% · PAT 17.5% · OPM change -1 pp 100% evidence | 16.5/25 ROCE 20.2% · OPM 30% 100% evidence | 4.9/20 P/E 65.2× · PEG 4 100% evidence | 10.2/20 RS sector 8.7% · RS bench -12.5% · 1Y -19.1%1 of 10 weeks ahead 70% evidence |
| Exact sum: 16.4 + 16.5 + 4.9 + 10.2 = 48 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression. | ||||||
| 4Relaxo Footwears LtdRELAXO | 36.6/100Mixed-negative evidence90% evidence | BREAKING OUT | 13.2/35 Revenue -3.1% · PAT 5.9% · OPM change 1 pp 88% evidence | 11.6/25 ROCE 11.1% · OPM 17% 100% evidence | 2.3/20 P/E 58.8× · PEG 6.15 100% evidence | 9.5/20 RS sector -18.6% · RS bench 8.2% · 1Y -4.4%8 of 11 weeks ahead 70% evidence |
| Exact sum: 13.2 + 11.6 + 2.3 + 9.5 = 36.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Mirza International LtdMIRZAINT | 32.2/100Thin evidence · provisional57% evidence | 9.7/35 Revenue -9.3% · PAT 100% · OPM change -6.7 pp 95% evidence | 3.4/25 ROCE -1.8% · OPM 2.4% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 9.1/20 RS sector — · RS bench -7.6% · 1Y — 25% evidence | |
| Exact sum: 9.7 + 3.4 + 10 + 9.1 = 32.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 6Bata India LtdBATAINDIA | 31.6/100Adverse evidence80% evidence | ASLEEP | 7.3/35 Revenue 0.8% · PAT -59.4% · OPM change -4.3 pp 88% evidence | 12.4/25 ROCE 12.7% · OPM 18.2% 100% evidence | 8.9/20 P/E 55× · PEG — 50% evidence | 3.0/20 RS sector -19.7% · RS bench -19.9% · 1Y -39.3%0 of 10 weeks ahead 70% evidence |
| Exact sum: 7.3 + 12.4 + 8.9 + 3 = 31.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 7Campus Activewear LtdCAMPUS | 64.5/100Thin evidence · provisional45% evidence | ASLEEP | 20.5/35 Revenue — · PAT — · OPM change 7 pp 19% evidence | 18.1/25 ROCE 31.8% · OPM 18% 57% evidence | 13.4/20 P/E 50.5× · PEG — 50% evidence | 12.5/20 RS sector 13.5% · RS bench -13.9% · 1Y -16.1%0 of 10 weeks ahead 70% evidence |
| Exact sum: 20.5 + 18.1 + 13.4 + 12.5 = 64.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Sreeleathers Ltd's share price today?
Sreeleathers Ltd trades at ₹217. The company is valued at ₹501 Cr. The stock sits at 74% of its 52-week range of ₹184–₹228, +3.1% versus its 200-day average. On the tape, the price is building a base, 3 weeks in. — as of 7 August 2026.
What were Sreeleathers Ltd's latest quarterly results?
Sreeleathers Ltd reported revenue of ₹62.7 Cr and net profit of ₹9.7 Cr for the Mar 26 quarter. Revenue rose 17.9% and profit rose 82.8% year on year. Earnings per share were ₹4.18. The operating margin was 15.9%, 3.3 pp higher than a year earlier. — as of 7 August 2026.
What is Sreeleathers Ltd's revenue?
Sreeleathers Ltd reported revenue of ₹62.7 Cr in the Mar 26 quarter, +17.9% year on year. For the full FY26 fiscal year, revenue was ₹248 Cr (+14.3%). Over the last 10 years revenue compounded at 12.0% a year. — as of 7 August 2026.
What is Sreeleathers Ltd's profit?
Sreeleathers Ltd earned ₹9.7 Cr of net profit in the Mar 26 quarter, +82.8% year on year — the 3rd straight quarter of growth. Full-year FY26 profit was ₹29.0 Cr. The operating margin ran 15.9% in the latest quarter. — as of 7 August 2026.
What is Sreeleathers Ltd's market cap?
Sreeleathers Ltd's market capitalisation is ₹501 Cr at a share price of ₹217. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 7 August 2026.
What is Sreeleathers Ltd's P/E ratio?
Sreeleathers Ltd trades at a P/E of 17.4×, at the 16th percentile of its own 10-year range, against a long-run median of 24.4×. This is a comparison with the stock's own history, not a value call — as of 7 August 2026.
Does Sreeleathers Ltd pay a dividend?
Yes — Sreeleathers Ltd's dividend payout was 8% of profit in FY26, and it recorded a payout in 1 of its last 12 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 7 August 2026.
Is Sreeleathers Ltd overvalued?
On its own history, Sreeleathers Ltd looks cheap against its own history: its P/E of 17.4× has been cheaper only 16% of the time in 10 years (long-run median 24.4×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 7 August 2026.
Is Sreeleathers Ltd growing?
Yes — Sreeleathers Ltd is growing: latest-quarter revenue +17.9% year on year, profit +82.8%, and the margin +3.3 pp at 15.9%. The 10-year compound rates are 12.0% (revenue) and 10.2% (profit). The earnings engine currently reads: improving — as of 7 August 2026.
How is Sreeleathers Ltd performing?
Sreeleathers Ltd is building a base, 3 weeks in. Its latest quarter's revenue rose 17.9% and profit rose 82.8% year on year. This describes what the data did, not a rating. — as of 7 August 2026.
What stage is Sreeleathers Ltd in?
Improving — profit growth bottomed 8 quarters ago at −29.0% and has held its recovery at +82.8% (single-quarter readings), ROCE holding at 8.0%. The read comes from the last 12 quarters of growth (revenue growth +17.9% latest, profit growth +82.8% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 7 August 2026.
Is Sreeleathers Ltd in an uptrend?
No — the price is building a base (week 3 of stage 1), trading +3.1% versus its 200-day average and at 74% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 7 August 2026.
Will Sreeleathers Ltd's share price go up?
This page publishes no price forecast for Sreeleathers Ltd. What it measures instead: the share price is ₹217, the price is building a base 3 weeks in. Its P/E of 17.4× sits at the 16th percentile of its own 10-year range. Direction is not something this site claims to know. — as of 7 August 2026.
Who owns Sreeleathers Ltd?
Promoters hold 75.0% of Sreeleathers Ltd, foreign institutions 6.9%, domestic institutions null% and the public 18.1% (latest quarter). No holder moved a full point over the last two years — the register is quiet. — as of 7 August 2026.
Does Sreeleathers Ltd have too much debt?
No — Sreeleathers Ltd's debt-to-equity is 0.00, and operating profit covers the interest bill 38×. FY26 borrowings were ₹2.0 Cr against equity of ₹498 Cr. The returns on this page are earned, not borrowed — as of 7 August 2026.
What is Sreeleathers Ltd's capex?
Sreeleathers Ltd spent ₹3.0 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹0.0 Cr, with ₹0.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 7 August 2026.
What is Sreeleathers Ltd's cash flow?
Sreeleathers Ltd generated ₹31.0 Cr of operating cash flow in FY26 and ₹31.0 Cr of free cash flow after ₹0.0 Cr of capital spending. Reported profit that year was ₹29.0 Cr, so operating cash ran ahead of profit. Cash-flow resolution for India is annual. — as of 7 August 2026.
Is Sreeleathers Ltd's profit real cash?
Yes — over the last 3 fiscal years, 111% of Sreeleathers Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹31.0 Cr against reported profit of ₹29.0 Cr. The cash then goes into a mix of the working-capital cycle and capacity. Cash-flow resolution is annual — as of 7 August 2026.
Where is Sreeleathers Ltd in its business cycle?
Sreeleathers Ltd's FY26 operating margin was 14.0%, against a 12-year band of 14.0%–23.0%: the low end of its own band, which is where recoveries start when they come. The latest quarter ran 15.9%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 7 August 2026.
What could break the Sreeleathers Ltd story?
Biggest watch item: the price is not yet in a confirmed uptrend — timing risk, not thesis risk. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 7 August 2026.
Is Sreeleathers Ltd a stock worth studying right now?
This is not investment advice. The machine read: Sreeleathers Ltd is coiled. The quarters are improving, yet the P/E sits at the 16th percentile of its own 10-year range — the business is moving before the market. The sharpest open question: the next one or two quarters of delivery. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 7 August 2026.